| Stage | SYK | % of rev | IRMD | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $6.5B | 100.00% | $24M | 100.00% | SYK ×269.39 |
| Gross profit | $4.2B | 65.15% | $18M | 76.26% | IRMD +11.1pp |
| Operating income | $1.0B | 15.86% | $8M | 33.63% | IRMD +17.8pp |
| Pre-tax income | $997M | 15.29% | $9M | 35.81% | IRMD +20.5pp |
| Net income | $753M | 11.55% | $7M | 26.88% | IRMD +15.3pp |
| Stage | SYK | IRMD | Gap · A − B |
|---|---|---|---|
| Revenue | $6.5B100.00% | $24M100.00% | SYK ×269.39 |
| Gross profit | 65.15%$4.2B | 76.26%$18M | IRMD +11.1pp |
| Operating income | 15.86%$1.0B | 33.63%$8M | IRMD +17.8pp |
| Pre-tax income | 15.29%$997M | 35.81%$9M | IRMD +20.5pp |
| Net income |
| 11.55%$753M |
| 26.88%$7M |
| IRMD +15.3pp |
No shared counterparties.